Named Patient Program (NPP), part of Ikris Pharma Network, is an Indian company that helps patients and healthcare providers access prescribed medicines that are not commercially available or not yet approved in India.

A Named Patient Program (also called Managed Access, Compassionate Use or Early Access Program) allows a treating doctor to request a specific medicine for an individual patient. NPP manages this process end to end: prescription and document review, transparent pricing and timelines, regulatory paperwork as per CDSCO requirements, and sourcing through a trusted global pharmaceutical network.

Medicines are delivered with EU-GDP compliant, temperature-controlled logistics and 24/7 temperature monitoring. NPP covers therapy areas such as oncology, hematology, rare diseases, neurology, endocrinology, immunology, nephrology and more.

Key facts: 30+ years of expertise, 15,000+ patients served, 50+ hospitals and institutions served, 1.5 million+ product lines.

Access is strictly subject to a valid prescription from a licensed medical practitioner. Office: 905, 9th Floor, Tower A, I-Thum Business Park, Sector 62, Noida, Uttar Pradesh 201301. Hours: Monday to Saturday, 10:00 AM to 7:00 PM. Website: https://namedpatientprogram.com/